Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion

Am J Hematol. 1994 Feb;45(2):187-8. doi: 10.1002/ajh.2830450218.

Abstract

We report two patients who experienced severe reversible encephalopathy following infusion of peripheral blood stem cells cryopreserved in 10% dimethylsulfoxide (DMSO). In one patient, reduction of DMSO level with plasmapheresis resulted in marked improvement in encephalopathy. Infusion of large volumes of cryopreserved stem cells may result in a significant toxic reaction. Plasmapheresis may be a treatment option for patients with significant toxicity related to DMSO.

Publication types

  • Case Reports

MeSH terms

  • Brain Diseases / etiology*
  • Brain Diseases / therapy
  • Cell Transplantation / adverse effects*
  • Cryopreservation
  • Dimethyl Sulfoxide / pharmacology
  • Hematopoietic Stem Cell Transplantation*
  • Hematopoietic Stem Cells / drug effects
  • Humans
  • Male
  • Middle Aged
  • Plasmapheresis

Substances

  • Dimethyl Sulfoxide